CEO MONTHLY / GLOBAL CEO EXCELLENCE AWARDS 2019 31 , Jun19249 ImmuPharma PLC is a pharmaceutical research firm at the forefront of medical innovation, dedicated to the development of innovative medicines to treat serious medical conditions. We share an overview of the firm and how CEO and Co-Founder Dimitri Dimitriou has helped to drive it to the international renown it currently enjoys. Pharma CEO of the Year 2019 - Western Europe First founded 20 years ago in Basel, Switzerland and led by an experienced management team, ImmuPharma now has important R&D collaboration arrangements with highly respected health and medical research laboratories in Europe and has progressed a number of novel drug candidates. Today, with its headquarters in London and with research operations in France and Switzerland, ImmuPharma has reached the final stages of clinical development and its lead product has been tested in hundreds of patients. CEO and Co-Founder Dimitri Dimitriou has over 30 years’ experience in the pharmaceutical and biotech industry and is still driven by his passion to help people’s health. ImmuPharma is a public company, listed on AIM of the London Stock Exchange for almost 15 years and has raised substantial funding for its medical research. His past roles include Senior Director, Worldwide Business Development at GlaxoSmithKline, responsible for collaborations with pharmaceutical and biotech companies. He held a similar role in Europe for Bristol-Myers Squibb. Prior to that, he spent 8 years at Procter & Gamble’s pharmaceutical division based partly at the European Research & Development centre. He began his career in marketing at Novartis in 1987. Alongside his extensive industry experience, he also has two degrees from the University of London - a Bachelor’s in biochemistry from Kings College and a Master’s in pathology and toxicology from Imperial College Medical School. Looking to the future, ImmuPharma plans either to bring its drug candidates to market itself, or to license them in corporate deals to other pharmaceutical companies. Dimitri will be striving to drive the company to even greater acclaim and secure its place among the world’s greatest biotech companies. Company: ImmuPharma plc Contact: Dimitri Dimitriou Website: www.immupharma.co.uk Dimitri Dimitriou, ImmuPharma PLC
RkJQdWJsaXNoZXIy NTY1MjI4